243 related articles for article (PubMed ID: 32532289)
21. Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes.
Oga T; Yamashita Y; Soda M; Kojima S; Ueno T; Kawazu M; Suzuki N; Nagano H; Hazama S; Izumiya M; Koike K; Mano H
Cancer Sci; 2019 Sep; 110(9):2973-2981. PubMed ID: 31293054
[TBL] [Abstract][Full Text] [Related]
22. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
[TBL] [Abstract][Full Text] [Related]
23. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
[TBL] [Abstract][Full Text] [Related]
24. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
Bissig-Choisat B; Kettlun-Leyton C; Legras XD; Zorman B; Barzi M; Chen LL; Amin MD; Huang YH; Pautler RG; Hampton OA; Prakash MM; Yang D; Borowiak M; Muzny D; Doddapaneni HV; Hu J; Shi Y; Gaber MW; Hicks MJ; Thompson PA; Lu Y; Mills GB; Finegold M; Goss JA; Parsons DW; Vasudevan SA; Sumazin P; López-Terrada D; Bissig KD
J Hepatol; 2016 Aug; 65(2):325-33. PubMed ID: 27117591
[TBL] [Abstract][Full Text] [Related]
25. Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN.
Codrich M; Dalla E; Mio C; Antoniali G; Malfatti MC; Marzinotto S; Pierobon M; Baldelli E; Di Loreto C; Damante G; Terrosu G; Pucillo CEM; Tell G
J Exp Clin Cancer Res; 2021 Jun; 40(1):198. PubMed ID: 34154611
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
27. Transcriptome analysis of paired primary colorectal carcinoma and liver metastases reveals fusion transcripts and similar gene expression profiles in primary carcinoma and liver metastases.
Lee JR; Kwon CH; Choi Y; Park HJ; Kim HS; Jo HJ; Oh N; Park do Y
BMC Cancer; 2016 Jul; 16():539. PubMed ID: 27461012
[TBL] [Abstract][Full Text] [Related]
28. Novel patient-derived preclinical models of liver cancer.
Bresnahan E; Ramadori P; Heikenwalder M; Zender L; Lujambio A
J Hepatol; 2020 Feb; 72(2):239-249. PubMed ID: 31954489
[TBL] [Abstract][Full Text] [Related]
29. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
[TBL] [Abstract][Full Text] [Related]
30. c-Met-Targeting
Li D; Yang J; Xu Z; Li Y; Sun Y; Wang Y; Zou H; Wang K; Yang L; Wu L; Sun X
Int J Nanomedicine; 2023; 18():2181-2196. PubMed ID: 37131548
[TBL] [Abstract][Full Text] [Related]
31. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
32. Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma.
Kobayashi H; Gieniec KA; Ng JQ; Goyne J; Lannagan TRM; Thomas EM; Radford G; Wang T; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Burt AD; Takahashi M; Enomoto A; Worthley DL; Woods SL
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34542536
[TBL] [Abstract][Full Text] [Related]
33. Japanese experience with hepatic resection of KRAS-mutated colorectal liver metastases.
Shindoh J
Chin Clin Oncol; 2019 Oct; 8(5):47. PubMed ID: 31500425
[TBL] [Abstract][Full Text] [Related]
34. Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
Roy P; Canet-Jourdan C; Annereau M; Zajac O; Gelli M; Broutin S; Mercier L; Paci A; Lemare F; Ducreux M; Elias D; Malka D; Boige V; Goéré D; Jaulin F
Int J Pharm; 2017 Oct; 531(1):143-152. PubMed ID: 28803938
[TBL] [Abstract][Full Text] [Related]
35. Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples.
Choi SI; Jeon AR; Kim MK; Lee YS; Im JE; Koh JW; Han SS; Kong SY; Yoon KA; Koh YH; Lee JH; Lee WJ; Park SJ; Hong EK; Woo SM; Kim YH
Front Oncol; 2019; 9():875. PubMed ID: 31572675
[TBL] [Abstract][Full Text] [Related]
36. Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
Oshiro H; Tome Y; Kiyuna T; Yoon SN; Lwin TM; Han Q; Tan Y; Miyake K; Higuchi T; Sugisawa N; Katsuya Y; Park JH; Zang Z; Razmjooei S; Bouvet M; Clary B; Singh SR; Kanaya F; Nishida K; Hoffman RM
Anticancer Res; 2019 Sep; 39(9):4667-4671. PubMed ID: 31519565
[TBL] [Abstract][Full Text] [Related]
37. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
[TBL] [Abstract][Full Text] [Related]
38. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer.
He X; Jiang Y; Zhang L; Li Y; Hu X; Hua G; Cai S; Mo S; Peng J
Front Bioeng Biotechnol; 2023; 11():1190637. PubMed ID: 37284236
[No Abstract] [Full Text] [Related]
39. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.
Narasimhan V; Wright JA; Churchill M; Wang T; Rosati R; Lannagan TRM; Vrbanac L; Richardson AB; Kobayashi H; Price T; Tye GXY; Marker J; Hewett PJ; Flood MP; Pereira S; Whitney GA; Michael M; Tie J; Mukherjee S; Grandori C; Heriot AG; Worthley DL; Ramsay RG; Woods SL
Clin Cancer Res; 2020 Jul; 26(14):3662-3670. PubMed ID: 32376656
[TBL] [Abstract][Full Text] [Related]
40. Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.
Wang S; Zhang C; Zhang Z; Qian W; Sun Y; Ji B; Zhang Y; Zhu C; Ji D; Wang Q; Sun Y
Cancer Med; 2017 Aug; 6(8):1976-1987. PubMed ID: 28745433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
